-
1
المؤلفون: Francesco Cognetti, Cecilia Nisticò, Maria Ciolina, Elena Giordani, Matteo Allegretti, Diana Giannarelli, Patrizio Giacomini, Vittoria Barberi, Paolo Romania, Gennaro Ciliberto, Alessandra Fabi, Cristiana Ercolani, Simona Gasparro, Edoardo Pescarmona
المصدر: Molecular Cancer, Vol 20, Iss 1, Pp 1-6 (2021)
Molecular Cancerمصطلحات موضوعية: Adult, Oncology, Cancer Research, medicine.medical_specialty, Pharmacological resistance, Receptor, ErbB-2, T-DM1, Breast Neoplasms, Biology, Ado-Trastuzumab Emtansine, chemistry.chemical_compound, Internal medicine, HER2 Positive Breast Cancer, Biomarkers, Tumor, medicine, Humans, Liquid biopsy, Letter to the Editor, RC254-282, Aged, Neoplasm Staging, Aged, 80 and over, Circulating tumor DNA, Gene Amplification, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, HER2+ breast cancer, Middle Aged, Prognosis, chemistry, Drug Resistance, Neoplasm, Trastuzumab emtansine, Disease Progression, Molecular Medicine, Female, Neoplasm Grading
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::067c6b708666fe35787ba3b8bc34dbe0Test
https://doaj.org/article/bd5df440505045f68ad0544ebd6f26e2Test -
2
المؤلفون: Marya Obeidat, Marwa Barukba, Amr Masaadeh, Khaldon Bodoor, Rowida Almomani, Mohammad Alqudah
المصدر: Asian Pacific Journal of Cancer Prevention : APJCP
مصطلحات موضوعية: Adult, Oncology, medicine.medical_specialty, Receptor, ErbB-2, PPP1R16B, Breast Neoplasms, PR, Metastasis, Breast cancer, Downregulation and upregulation, Negatively associated, HER2, Internal medicine, Biomarkers, Tumor, medicine, Humans, Aged, Aged, 80 and over, Tissue microarray, biology, business.industry, HER2 negative, Membrane Proteins, General Medicine, Transforming growth factor beta, Middle Aged, medicine.disease, Up-Regulation, Survival Rate, ER, biology.protein, Immunohistochemistry, Female, business, Research Article
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9ac2252e6d1fa948febe458d089699aTest
https://doi.org/10.31557/apjcp.2021.22.6.1899Test -
3
المؤلفون: Yukiko Miyamura, Shunji Kamigaki, Jun Yamamura, Yukihiko Hahimot, Hironobu Manabe, Yoshifumi Komoike, Toshikazu Ito, Junya Fujita, Yumiko Tanaka, Hiroki Osato, Wataru Shinzaki
المصدر: Breast Disease. 41:109-114
مصطلحات موضوعية: Adult, Oncology, Cancer Research, medicine.medical_specialty, Receptor, ErbB-2, medicine.medical_treatment, Endocrine resistance, Breast Neoplasms, Young Adult, Breast cancer, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Endocrine system, Longitudinal Studies, First Recurrence, Aged, Retrospective Studies, Aged, 80 and over, business.industry, HER2 negative, General Medicine, Middle Aged, medicine.disease, Hormones, Progression-Free Survival, Receptors, Estrogen, Drug Resistance, Neoplasm, Hormone receptor, Female, Receptors, Progesterone, business, Adjuvant, Hormone
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e5d3df542436dc73bcff8499b49de60Test
https://doi.org/10.3233/bd-210027Test -
4
المؤلفون: Hiroaki Kawashima, Michiko Tsuneizumi, Noriko Sagawa, Hirofumi Mukai, Miki Yamaguchi, Hiroji Iwata, Yutaka Yamamoto, Takuya Kawahara, Toshiro Mizuno, Masahiro Kashiwaba, Yukari Uemura, Masataka Sawaki, Tsutomu Takashima, Takahiro Nakayama, Kokoro Kobayashi, Naruto Taira, Tsuyoshi Saito, Hiroko Bando, Masato Takahashi, Shinichi Baba, Yasuo Ohashi
المصدر: Journal of Clinical Oncology. 39:2452-2462
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Receptor, ErbB-2, medicine.medical_treatment, MEDLINE, Breast Neoplasms, Anxiety, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Older patients, Quality of life, Trastuzumab, Internal medicine, HER2 Positive Breast Cancer, Antineoplastic Combined Chemotherapy Protocols, Adjuvant therapy, Humans, Multicenter Studies as Topic, Medicine, 030212 general & internal medicine, Aged, Randomized Controlled Trials as Topic, Aged, 80 and over, Chemotherapy, Depression, business.industry, Age Factors, Peripheral Nervous System Diseases, Clinical Trials, Phase III as Topic, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Quality of Life, Female, business, Adjuvant, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2a83f4d7ccdbb436dac1bf2553c3720Test
https://doi.org/10.1200/jco.20.02751Test -
5
المؤلفون: Qianyi Lu, Ruoxi Hong, Wen Xia, Kuikui Jiang, Chenge Song, Zhongyu Yuan, Yuyu Ma, Fangfang Duan, Xiwen Bi, Jia Jia Huang, Fei Xu, Shusen Wang, Zhangzan Huang
المصدر: Drug Design, Development and Therapy
مصطلحات موضوعية: Oncology, Adult, medicine.medical_specialty, Time Factors, overall survival, Pharmaceutical Science, Antineoplastic Agents, Breast Neoplasms, Predictive Value of Tests, Internal medicine, Drug Discovery, Overall survival, Medicine, Humans, Progression-free survival, Neoplasm Metastasis, Original Research, Aged, Retrospective Studies, Pharmacology, Drug Design, Development and Therapy, Everolimus, business.industry, HER2 negative, Cancer, Nomogram, Middle Aged, medicine.disease, everolimus, Prognosis, Metastatic breast cancer, Confidence interval, Progression-Free Survival, Survival Rate, Nomograms, prognostic nomogram, Female, metastatic breast cancer, business, medicine.drug, Follow-Up Studies
وصف الملف: text/html
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::471b147ef799346873e11408bf9d31feTest
http://europepmc.org/articles/PMC8364432Test -
6
المؤلفون: Xiang Y. Ye, Jacques Raphael, Theodore A. Vandenberg, R. Gabriel Boldt, Phillip S. Blanchette, Prakesh S. Shah, Paul Stewart, Ricardo J. Fernandes
المصدر: The Breast : Official Journal of the European Society of Mastology
Breast, Vol 54, Iss, Pp 203-210 (2020)مصطلحات موضوعية: Oncology, Cancer Research, Time Factors, Receptor, ErbB-2, medicine.medical_treatment, Disease, law.invention, Antineoplastic Agents, Immunological, 0302 clinical medicine, Randomized controlled trial, Trastuzumab, law, HER2 Positive Breast Cancer, Medicine, Breast, 030212 general & internal medicine, skin and connective tissue diseases, Adjuvant, Randomized Controlled Trials as Topic, Standard treatment, Absolute risk reduction, General Medicine, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Treatment Outcome, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Meta-analysis, Original Article, Female, medicine.drug, Adult, medicine.medical_specialty, Breast Neoplasms, Subgroup analysis, Equivalence Trials as Topic, lcsh:RC254-282, Disease-Free Survival, 03 medical and health sciences, HER2, Internal medicine, Humans, Aged, business.industry, Surgery, business, 030215 immunology
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddde748c9f470e9d059d7e0e2f13e997Test
https://doi.org/10.1016/j.breast.2020.10.003Test -
7
المؤلفون: Momal Chand, Valentina Hoyos, Jason A Mouabbi, Daniel Ockner, Mothaffar F. Rimawi, Amr Aref, Tarik Hadid, Ramen Sakhi, Carrie L. Dul, Ishaq A. Asghar
المصدر: Cancer Medicine, Vol 10, Iss 14, Pp 4790-4795 (2021)
Cancer Medicineمصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, Time Factors, Receptor, ErbB-2, medicine.medical_treatment, Triple Negative Breast Neoplasms, Kaplan-Meier Estimate, Mastectomy, Segmental, radiation therapy, tumor‐infiltrating lymphocytes, 0302 clinical medicine, Medicine, Stage (cooking), skin and connective tissue diseases, Triple-negative breast cancer, Mastectomy, RC254-282, Original Research, Aged, 80 and over, Lumpectomy, Age Factors, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, hemic and immune systems, Middle Aged, Combined Modality Therapy, 030220 oncology & carcinogenesis, Female, TNBC, Adult, HER2+, medicine.medical_specialty, Antineoplastic Agents, Breast Neoplasms, chemical and pharmacologic phenomena, Disease-Free Survival, 03 medical and health sciences, Breast cancer, Lymphocytes, Tumor-Infiltrating, breast cancer, Internal medicine, Humans, Radiology, Nuclear Medicine and imaging, TILs, Aged, Neoplasm Staging, Retrospective Studies, Radiotherapy, business.industry, Tumor-infiltrating lymphocytes, triple‐negative, Clinical Cancer Research, medicine.disease, Radiation therapy, 030104 developmental biology, Histopathology, Neoplasm Recurrence, Local, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b43451735322b9542c100cf189a4da92Test
https://doaj.org/article/c6a62fe8c1c74ba0a71fb27937d91dcaTest -
8
المؤلفون: Kadir Eser, Pinar Saip, Erdem Cubukcu, Fuat Demirelli, Ozkan Alan, Zuleyha Calikusu, Aykut Bahceci, Ali Alkan, Hacer Demir, Mahmut Büyükşimşek, Cemile Karadeniz, Erhan Gokmen, Naziye Ak, Mehmet Bilici, Altay Aliyev, Turkkan Evrensel, Oznur Bal, Atakan Demir, Özge Keskin, Nilgün Yildirim, Saadettin Kilickap, Semra Paydas, Atike Gökçen Demiray, Kezban Nur Pilanci, Ali Gökyer, Perran Fulden Yumuk, Birol Yildiz, Duygu Ilke Cikman, Ismail Beypinar, Taner Korkmaz, Sinan Yavuz, Burcu Çakar, Erkan Arpaci, Gulsah Seydaoglu, Ferhat Ferhatoglu, Ahmet Z. Sahin, Gulcan Bulut, Serkan Degirmencioglu, Cengiz Karacin, Mutlu Dogan, Havva Yesil Cinkir, Kerem Okutur, Semiha Urvay, Deniz Işik, Melih Simsek, Osman Kostek, Meltem Baykara, Salim Basol Tekin, Deniz Yamac
المساهمون: ŞİMŞEK, MELİH
المصدر: Cancer Investigation. 39:473-481
مصطلحات موضوعية: Oncology, Turkey, retrospective study, T-DM1, diarrhea, heart failure, thrombocytopenia, 0302 clinical medicine, aspartate aminotransferase, infusion related reaction, estrogen, genetics, Neoplasm Metastasis, cancer survival, skin and connective tissue diseases, Aged, 80 and over, progression free survival, portal hypertension, clinical trial, General Medicine, nausea, anemia, Metastatic breast cancer, 030220 oncology & carcinogenesis, immunological antineoplastic agent, oral mucositis, musculoskeletal diseases, medicine.medical_specialty, progesterone, Article, multiple cycle treatment, paresthesia, hypomagnesemia, 03 medical and health sciences, turkey (bird), neutropenia, metastasis, Humans, human, acne, cystitis, neoplasms, human epidermal growth factor receptor 2 positive breast cancer, Aged, Retrospective Studies, trastuzumab emtansine, hypophosphatemia, leukopenia, ERBB2 protein, human, thromboembolism, hyperkalemia, medicine.disease, major clinical study, Survival Analysis, drug efficacy, multicenter study, 030104 developmental biology, chemistry, epidermal growth factor receptor 2, fatigue, proteinuria, disease activity, drug tolerability, drug hypersensitivity, 0301 basic medicine, vomiting, Cancer Research, drug safety, hyponatremia, Survival, Receptor, ErbB-2, very elderly, efficacy, hyperuricemia, hypocalcemia, Ado-Trastuzumab Emtansine, Turkey (republic), chemistry.chemical_compound, Antineoplastic Agents, Immunological, brain metastasis, pain, lapatinib, hypernatremia, breast tumor, Middle Aged, visceral metastasis, humanities, trastuzumab, Treatment Outcome, gamma glutamyltransferase, immunohistochemistry, Female, real world experience.-, Cancer investigation, ss.1-22, 2021 [Bahçeci A., Paydaş S., Ak N., Ferhatoğlu F., Saip P. M. , Seydaoğlu G., Bilici M., Şimşek M., Tekin S. B. , Çalikuşu Z., et al., -Efficacy and safety of trastuzumab emtansine in Her2 positive metastatic breast cancer], bilirubin, alkaline phosphatase, Receptor, Adult, congenital, hereditary, and neonatal diseases and abnormalities, side effect, alanine aminotransferase, overall survival, Breast Neoplasms, spine metastasis, delirium, male, pertuzumab, acute kidney failure, Internal medicine, hypokalemia, medicine, pneumonia, controlled study, fluorescence in situ hybridization, business.industry, liver failure, hypercalcemia, hypertransaminasemia, toxicity, alopecia, hand foot syndrome, human tissue, real-world experience, clinical feature, febrile neutropenia, hypoglycemia, Trastuzumab emtansine, hyperglycemia, business, metabolism
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e995dc25bd5d60e4fc0b04e58d82c9eaTest
https://doi.org/10.1080/07357907.2021.1933011Test -
9
المؤلفون: Yanshuo Cao, Lin Shen, Jiajia Yuan, Jifang Gong, Chenyu Mao, Da Jiang, Jianmin Fang, Yuxian Bai, Zhenghang Wang, Xinan Sheng, Qingxia Fan, Changsong Qi, Yi Ba, Dan Liu, Fen Yang, Yakun Wang, Yingying Xu, Zhi Peng, Ming Lu, Xiaotian Zhang, Jian Li, Xicheng Wang, Jun Zhou
المصدر: Gastric Cancer
مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Immunoconjugates, Maximum Tolerated Dose, Receptor, ErbB-2, Bilirubin, RC48-ADC, Neutropenia, Antibodies, Monoclonal, Humanized, Gastroenterology, chemistry.chemical_compound, Antineoplastic Agents, Immunological, Stomach Neoplasms, Surgical oncology, HER2, Internal medicine, Solid tumors, medicine, Humans, Aged, Leukopenia, biology, business.industry, Cancer, General Medicine, Middle Aged, medicine.disease, Treatment Outcome, Oncology, chemistry, Toxicity, biology.protein, Immunohistochemistry, Original Article, Female, Antibody, medicine.symptom, Gastric cancer, business, Oligopeptides
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a20a5a03b8e4fcae069076c9eb83ed4fTest
https://doi.org/10.1007/s10120-021-01168-7Test -
10
المؤلفون: Cristina Reboredo, Lucía García-Caballero, Ángel Vázquez-Boquete, Ángel Concha, Mari Paz Santiago, Aurea Molina, Tomás García-Caballero, Silvia Antolín, Eva Pérez, Lourdes Calvo, Rosalía Gallego, Joaquín Mosquera
المصدر: Virchows Archiv. 479:853-857
مصطلحات موضوعية: Adult, 0301 basic medicine, Oncology, medicine.medical_specialty, Receptor, ErbB-2, medicine.medical_treatment, Breast Neoplasms, Biomarkers, Pharmacological, Pathology and Forensic Medicine, Correlation, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Trastuzumab, Neoadjuvant treatment, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, HER2 Amplification, skin and connective tissue diseases, neoplasms, Molecular Biology, In Situ Hybridization, Fluorescence, Neoadjuvant therapy, Aged, Chemotherapy, business.industry, Gene Amplification, Cell Biology, General Medicine, Middle Aged, medicine.disease, Neoadjuvant Therapy, Treatment Outcome, 030104 developmental biology, 030220 oncology & carcinogenesis, Female, Breast carcinoma, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a76c2bc10270e47465677cc689b762c3Test
https://doi.org/10.1007/s00428-021-03104-7Test